Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New WaferGen Execs, Nanosphere Board Member, Insight Genetics Scientists

Premium

WaferGen Biosystems said this week that it has appointed Keith Warner as chief operating officer and Michael Henighan as CFO.

Prior to joining WaferGen, Warner served as a consultant to several life science investment firms since 2009. He has also served as vice president of worldwide marketing for Novartis/Chiron and CEO of Biodesix, and earlier in his career held numerous positions of increasing responsibility in manufacturing, sales and marketing, and management at Abbott Diagnostics.

Henighan was a founder and CFO of Aplegen since early 2011. From 1997 to 2011, he served as either CFO or corporate controller at Alpha Innotech, HemoSense, and Cholestech. He also previously held senior management positions with Solectron, Applied Biosystems, and Motorola.


Nanosphere this week announced the appointment of Kristopher Wood to its board of directors.

Wood is currently the sole member of Highline Partners, a consultancy through which he serves in the capacity of chief investment officer at Lurie Holdings, and as special advisor on strategic matters to New Page Corporation and its board of directors. Prior to forming Highline Partners, Wood served as head of strategy and corporate development at WorldColor Press. He has also been an associate at private equity investment firm MidOcean Partners, chief acquisitions officer for Glenayre, and managing director for mergers and acquisitions and venture capital at Vertis Holdings, and its predecessor, Big Flower Holdings.


Insight Genetics said this week that it has named Kasey Lawrence as senior technology specialist and Tyler Nielsen as research scientist.

Lawrence will oversee day-to-day operations of Insight Genetics' next-generation sequencing program. Previously, he was a research associate. He holds a BS in biology from Tennessee Tech University. Nielsen will coordinate projects and manage resources in Insight's research laboratory for companion diagnostic development. He was also previously a research associate, and he received an MA in biomedical science from Des Moines University.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.